In 2008, Liang et al. [32] supplemented patients undergoing radical colorectal cancer resection with FO-enriched PN and showed a reduction in interleukin (IL)-6, a high CD4+/CD8+ ratio, and higher CD3+ and CD4+ lymphocytes. The gene discussed is CD8A; the disease is colorectal cancer.